NL8800805A - Gesubstitueerde 1,3-dioxolaan en 1,3-dioxaanderivaten, werkwijzen voor de bereiding van deze derivaten en hun toepassing. - Google Patents

Gesubstitueerde 1,3-dioxolaan en 1,3-dioxaanderivaten, werkwijzen voor de bereiding van deze derivaten en hun toepassing. Download PDF

Info

Publication number
NL8800805A
NL8800805A NL8800805A NL8800805A NL8800805A NL 8800805 A NL8800805 A NL 8800805A NL 8800805 A NL8800805 A NL 8800805A NL 8800805 A NL8800805 A NL 8800805A NL 8800805 A NL8800805 A NL 8800805A
Authority
NL
Netherlands
Prior art keywords
tolyl
dioxolane
formula
compound
butyl
Prior art date
Application number
NL8800805A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8800805A publication Critical patent/NL8800805A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
NL8800805A 1987-04-01 1988-03-30 Gesubstitueerde 1,3-dioxolaan en 1,3-dioxaanderivaten, werkwijzen voor de bereiding van deze derivaten en hun toepassing. NL8800805A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3411887A 1987-04-01 1987-04-01
US3411887 1987-04-01

Publications (1)

Publication Number Publication Date
NL8800805A true NL8800805A (nl) 1988-11-01

Family

ID=21874422

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8800805A NL8800805A (nl) 1987-04-01 1988-03-30 Gesubstitueerde 1,3-dioxolaan en 1,3-dioxaanderivaten, werkwijzen voor de bereiding van deze derivaten en hun toepassing.

Country Status (18)

Country Link
JP (1) JPS63277672A (pt)
KR (1) KR880012224A (pt)
AU (1) AU1400788A (pt)
BE (1) BE1000783A3 (pt)
DE (1) DE3810874A1 (pt)
DK (1) DK179288A (pt)
ES (1) ES2011831A6 (pt)
FR (1) FR2613226B1 (pt)
GB (1) GB2202849A (pt)
GR (1) GR880100196A (pt)
HU (1) HUT50156A (pt)
IL (1) IL85920A0 (pt)
IT (1) IT1219895B (pt)
LU (1) LU87176A1 (pt)
NL (1) NL8800805A (pt)
PT (1) PT87127B (pt)
SE (1) SE8801166L (pt)
ZA (1) ZA882350B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701961D0 (en) * 1987-01-29 1987-03-04 Unilever Plc Perfumery materials

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3235589A1 (de) * 1982-09-25 1984-03-29 Hoechst Ag, 6230 Frankfurt Benzylether von phenol-mannich-basen, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
GB2202849A (en) 1988-10-05
ES2011831A6 (es) 1990-02-16
FR2613226B1 (fr) 1989-09-15
IT8847797A0 (it) 1988-03-30
BE1000783A3 (fr) 1989-04-04
PT87127B (pt) 1992-07-31
KR880012224A (ko) 1988-11-26
IL85920A0 (en) 1988-09-30
DE3810874A1 (de) 1988-10-20
PT87127A (pt) 1988-04-01
SE8801166D0 (sv) 1988-03-29
IT1219895B (it) 1990-05-24
GB8807503D0 (en) 1988-05-05
JPS63277672A (ja) 1988-11-15
DK179288D0 (da) 1988-03-30
AU1400788A (en) 1988-10-06
DK179288A (da) 1988-10-02
FR2613226A1 (fr) 1988-10-07
ZA882350B (en) 1989-12-27
SE8801166L (sv) 1988-10-02
LU87176A1 (fr) 1988-11-17
GR880100196A (el) 1989-01-31
HUT50156A (en) 1989-12-28

Similar Documents

Publication Publication Date Title
EP0017195B1 (en) Derivatives of 2,5-disubstituted-cyclohexane-1,3-diones, process for preparation thereof and pharmaceutical composition containing them
US3174901A (en) Process for the oral treatment of diabetes
JPH07502487A (ja) 血糖低下性チアゾリジンジオンとその中間体
BE1003632A3 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments.
NL8800805A (nl) Gesubstitueerde 1,3-dioxolaan en 1,3-dioxaanderivaten, werkwijzen voor de bereiding van deze derivaten en hun toepassing.
US3923994A (en) Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity
JPS61275275A (ja) 1,3−ジチオ−ル−2−イリデン誘導体
US3953601A (en) Dibenzothiophene derivatives as serum lipid lowering agents
NL8101987A (nl) De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat.
US3332846A (en) Method of inducing hypoglycemia with a substituted indole
EP0534655B1 (en) Thiazolidine-2,4-diones in the treatment of hypertension
US4320135A (en) Inhibiting growth hormone secretion with 5,5-substituted hydantoin derivatives
KR950003499B1 (ko) 1,3,5-트리티안 유도체
US3941888A (en) Substituted or unsubstituted p-alkanoyl toluenes as hypolipidemics
US3968247A (en) Substituted or unsubstituted p-alkanoyl toluenes as anti-diabetic agents
FR2605006A1 (fr) Derives du 5-fluorouracile, procede pour leur preparation, composition anticancereuse les contenant et leur utilisation pour la preparation d'une composition destinee au traitement d'un cancer
US3953600A (en) Citronellyl benzimidazoles
US3222365A (en) 4-halophenyl-2-alkyl-1(2)-phthalazinones
US3562256A (en) 1,3-dialkyl-5-(substituted arylsulfonyl)-tetrahydro-1,3,5-triazine-4-thiones
US4057630A (en) Antiarthritic compositions comprising bis-coordinated gold(1+) salts and methods of producing antiarthritic activity
JPS6029693B2 (ja) 1−オキソ−2,2−ジ置換−5−インダニロキシアルカノイツクアシツドの製法
JPH0256424A (ja) 肝疾患治療剤
JPH05953A (ja) 白内障予防及び治療剤
US3821378A (en) 2-amino-4,6-diphenethylamino-s-triazine as active serum cholesterol lowering agent
US4093719A (en) Antiarthritic compositions comprising bis[(trialkyl-phosphine)gold(I)]sulfides and methods of producing antiarthritic activity

Legal Events

Date Code Title Description
BV The patent application has lapsed